Lung transplant ‘may be an acceptable treatment’ for some with COVID-19 respiratory failure

Of more than 3,000 lung transplants performed in the U.S. from August 2020 to Sept. 30, 2021, 7% were performed to treat severe, irreversible lung damage caused by COVID-19, researchers reported in The New England Journal of Medicine.Further, more than half of these patients required ventilation or extracorporeal membrane oxygenation before lung transplant.

Read the full article here

Related Articles